BioMarin Pharmaceutical, Inc. (BMRN)

55.07 -1.01 (-1.80%) USD  |  NASDAQ  |  Jan 15, 16:00
55.07 0.00 (0.00%) After-Hours: 16:34
More

BioMarin Pharmaceutical Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade